Use of an intravenous sodium load in screening for primary hyperaldosteronism.
A sodium loading test was performed in 35 patients presenting with hypertension and hypokalemia. In 14 of these patients, intravenous administration of 0.9% saline (2 l in 4 h) on two consecutive days caused urinary aldosterone excretion to fall to values within the range for normal volunteers. The other 21 patients, in whom urinary aldosterone excretion did not decline following two days of saline loading, or in whom pronounced hypokalemia after the first day of loading precluded further saline infusion, were designated as having primary aldosteronism. Seventeen of this group underwent surgery and discrete adrenal adenomas were found in 16. When serum potassium concentration, plasma renin activity or the relationships of serum potassium to concurrent urinary potassium excretion or of urinary aldosterone excretion to plasma renin activity were used as alternative diagnostic criteria for primary aldosteronism, overlapping of the two groups occurred. It is concluded that measurement of urinary aldosterone excretion after intravenous sodium loading is a useful test in the test in the identification of primary aldosteronism due to aldosterone-producing adenoma. In this series the saline loading test was more specific in diagnosis than criteria based on serum and urinary potassium, plasma renin activity or unsuppressed aldosterone excretion.
D000306:Adrenal Cortex Neoplasms / Q000378:metabolism; D000315:Adrenalectomy; D000328:Adult; D004232:Diuretics / Q000009:adverse effects; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000628:therapy; D006973:Hypertension / Q000188:drug therapy; D007008:Hypokalemia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011863:Radioimmunoassay; D012083:Renin / Q000096:biosynthesis; D012964:Sodium / Q000652:urine
D004232:Diuretics; D012964:Sodium; D012083:Renin; D011188:Potassium